KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does KYORIN Pharmaceutical Co., Ltd. (KYRNF) operate in?
KYORIN Pharmaceutical Co., Ltd. belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is KYORIN Pharmaceutical Co., Ltd. (KYRNF) current stock price?
As of the latest data, KYORIN Pharmaceutical Co., Ltd. stock price is $10.31, with a previous close of $10.31.
What is KYORIN Pharmaceutical Co., Ltd. (KYRNF) current market capitalization?
KYORIN Pharmaceutical Co., Ltd. market cap is approximately 592.27 million.
What is KYORIN Pharmaceutical Co., Ltd. (KYRNF) Earnings Per Share (EPS)?
The trailing EPS is $0.40.
What is KYORIN Pharmaceutical Co., Ltd. (KYRNF) Price-to-Earnings (P/E) ratio?
KYORIN Pharmaceutical Co., Ltd. current P/E ratio is 25.78.
Does KYORIN Pharmaceutical Co., Ltd. (KYRNF) pay dividends?
Yes. KYORIN Pharmaceutical Co., Ltd. pays semiannual dividends with an annualized yield of 3.8% and an estimated annual payout of $0.39 per share.
When is the next ex-dividend date for KYORIN Pharmaceutical Co., Ltd. (KYRNF)?
The next ex-dividend date is scheduled for March 31, 2027.
What is KYORIN Pharmaceutical Co., Ltd. (KYRNF) beta (volatility) score?
KYORIN Pharmaceutical Co., Ltd. has a beta of -0.020, indicating lower volatility than the overall market.
